The study objective was to examine quality oversight efforts by Medicaid managed care organizations (MCOs) for children in a sample of ambulatory care institutions and private practices in New York City. This was a cross-sectional study of quality assurance priorities and strategies of MCOs and their impact date in institutions in New York City. Data were from structured interviews administered in 1997 to medical directors in the eight largest MCOs; and medical directors, heads of ambulatory pediatrics, and institutional pediatricians in a random sample of 15 institutions and 20 private office-based providers. Medical directors in MCOs reported that their main priority areas were the preventive care measures (e.g., immunization and lead screening) that they must report to the state. Knowledge of these MCO priority areas and monitoring activities was high for medical directors in the random sample, but decreased from these medical directors to heads of ambulatory pediatrics to institutional pediatricians, with the differences between the medical directors and institutional pediatricians significant (P < .05). However, 96% of the institutional pediatricians reported knowing their own institution's priorities and monitoring activities. In Dr. Fairbrother is from the
INTRODUCTION
Nationwide, the movement of Medicaid beneficiaries into managed care is progressing rapidly. By 1999, 17.8 million Medicaid recipients were enrolled in managed care, which was 56% of all recipients and 2.5 times the proportion enrolled 5 years earlier. ~ In New York City, the number of Medicaid recipients in managed care grew from approximately 100,000 to over 400,000 between 1993 and 1996 and has remained just under 400,000 from 1997 to 2000, or more than a quarter of all eligible individuals 2 (including 50,000 in a mandatory enrollment demonstration program in Brooklyn). Implementation of mandatory Medicaid managed care under a Section 1115 waiver began in New York City in July 1999 after the completion of the federal readiness review3; enrollment in managed care was voluntary before that time.
The reliance on managed care brought with it new opportunities and challenges for states in ensuring the quality of care provided to low-income children. 4~
States have responded in a variety of ways, most commonly by collecting data from managed care organizations (MCOs) on delivery of well child and preventive services, especially immunizations, and by imposing a wide range of other requirements and standards on MCOs. 6 New York collects data on a series of measures designed to examine managed care performance in several key areas.
The measures, which New York State calls the Quality Assurance Reporting Requirements (QARR), are adopted largely from the Health Plan Employer Data and Information Set (HEDIS) of the National Committee for Quality Assurance (NCQA) 7 with New York-specific measures added to address public health issues of particular significance in New York State, such as lead screening of children. 8
Since 1994, the State Department of Health has issued an annual report summarizing QARR measures for each MCO and recently started publishing a health plan report card for use by consumers.
Within this broad framework, MCOs have latitude to adopt their own corpo-rate strategies for ensuring that quality standards are met and for setting priorities for quality improvement. While data collection around HEDIS/QARR performance indicators planwide is required, MCOs have latitude to monitor performance of individual providers and devise their own strategies for encouraging performance improvements. 9 The state expects that, by collecting data from MCOs and attempting to compare their performance, MCOs will have incentive to design and implement interventions that will improve the quality of care. It is implied that, because MCOs enter into contracts with participating physicians, MCOs will have the legal and organizational ability to ensure compliance with the quality-of-care directives they issue.
This monitoring strategy is most appropriate for markets in which the majority of Medicaid recipients are enrolled in a small number of MCOs, each with a distinct, nonoverlapping provider network of individual physicians serving predominantly Medicaid patients and contracting directly with the MCO. In this type of environment, a performance measurement based on a sample or the universe of members from within the MCOs' provider network will be within the influence of the MCO. However, this monitoring strategy may be less well suited to markets characterized by a large number of MCOs with overlapping provider networks comprised not only of individual physicians, but also of ambulatory care institutions, which act as organizational and financial intermediaries between the MCO and individual physicians. 1~
The New York City Medicaid managed care program represents such a market and offers an opportunity to understand how MCOs attempt to influence and monitor the quality of pediatric care provided by physicians practicing in both private offices and ambulatory care institutions, such as neighborhood health centers and hospital outpatient clinics, where it is estimated that approximately half of New York City children receive their primary care. ~1 Previous studies have focused almost exclusively on the relationship between MCOs and individual office-based physicians. ~2-~4 However, less is known about potential differences in the abilities of MCOs to exert control over physicians under direct contract and over those employed by health care institutions of varying size, complexity, and mission. Little is known, in addition, about differences in corporate quality assurance strategies among MCOs serving poor children in New York City and the effect of these at the institutional and private provider levels.
This study describes the quality assurance priorities and strategies for the eight largest Medicaid managed care plans in New York City in 1997, presents the response of a representative sample of institutions and private officebased practices, and considers more generally the impact of Medicaid managed care on health care in these institutions m comparison to its impact in private settings.
METHODS
This was a cross-sectional study of the quality assurance priorities and strategies of MCOs and their impact to date in institutions in New York City. It relies on structured interview data from medical directors in the eight largest managed care plans in New York City and from medical directors, heads of ambulatory pediatrics, and pediatricians in 15 institutions and 20 private office-based providers in New York City.
SELECTION OF I~IANAGED CARE ORGANIZATIONS, INSTITUTIONS, AND PROVIDERS
As of July 1997, although 22 managed care plans were approved to enroll Medicaid children in New York City, the eight largest MCOs together accounted for over 80% of the enrollment. Is These eight MCOs were included in this study.
Consistent with the Medicaid emphasis, five of these MCOs were not for profit, four were provider sponsored, and only three had any commercial patients. At the time of the study, three were composed primarily of private practitioners in group or solo practice, three were center based, and two were hospital or center based. All eight had been established before 1992. Within each plan, the medical director was interviewed; in some cases, the medical director asked the director of quality assurance of the MCO to sit in on the interview.
The sampling frame consisted of institutions and private providers serving low-income children. For institutions, the sampling frame consisted of all municipal hospitals, voluntary hospitals, and neighborhood health centers located in neighborhoods where at least 40% of the population under age 15 was enrolled in Medicaid. 16 There were 50 institutions included: 11 municipal hospitals, 13 voluntary hospitals, and 26 neighborhood health care centers (6 of which were municipal diagnostic and treatment centers). Within this universe, institutions were selected randomly proportional to the size of their pediatric population, with estimated volume of immunizations given as a measure of size, so that larger institutions were more likely to be chosen. Selection of 15 institutions was made: 6 municipal hospitals, 4 voluntary hospitals, 3 municipal diagnostic and treatment centers, and 2 nonmunicipal neighborhood health centers.
In each institution, the medical director and head of ambulatory pediatrics were included automatically for interviews; two attending physicians were selected randomly from each hospital and one from each center. All selected respondents agreed to be interviewed. In two cases, the medical director was also the head of ambulatory pediatrics and was counted only once. The final sample for eligible children is used, virtually all the providers serving the Medicaid population participate in VFC. 17 The New York City Department of Health puts considerable effort into finding physicians who might be VFC eligible, and the list compiled is an exhaustive one, with specialists as well as primary care physicians and physicians who are no longer practicing included. Physicians on the list were eliminated from the sampling pool if they had retired (13), could not be located (29), or were specialists who did not give primary care services or physicians who saw very few children (16) . Another study sponsored by the Department of Health was ongoing in the same population to stimulate better immunization practices. The physicians participating in this study (n = 56) were also eliminated from the pool because we felt that the presence of immunization incentives would contaminate the results. Physicians participating in that study were selected randomly, and thus their elimination should not bias the remaining pool. The remaining pool was comprised of 131 VFC-participating physicians; 7t were selected randomly, and multiple attempts were made to contact them.
Of those physicians, 42 selected were eliminated because they only accepted feefor-service patients (21) or had fewer than 50 Medicaid managed care patients aged 2 years or less (21) . Of the remaining 29 physicians, 20 agreed to participate (response rate 69%). The final sample included 12 pediatricians, 2 family practitioners, and 6 with missing designations. Of the sample, 75% were board certified, and another 15% were board eligible. Interview instruments were designed to learn about corporate quality assur-ance priorities and strategies at the MCO level and response or level of awareness to these at the provider level. Interview instruments at the plan level asked about pediatric quality of care priorities, the corporate quality assurance strategies for monitoring performance and encouraging performance in these areas, incentives/ disincentives, and funding arrangements for primary care. Plans were asked specifically about the monitoring of the preventive care measures in the QARR, which is New York State's adaptation of the national HEDIS 18 standards. New York State at that time had added three well child and preventive care reporting requirements to those specified in HEDIS 3.0 for children under 2 years old: lead screening, hemoglobin/hematocrit, and physical growth. 19 Interviews with the medical director and head of ambulatory pediatrics at the institutions and pediatricians in both institutions and private settings asked about (1) the impact of managed care on clinical and administrative procedures, (2) knowledge of plan and institution priorities for pediatric quality of care, (3) awareness of corporate quality assurance strategies used to achieve goals, (4) provider incentives/disincentives to achieve quality objectives, and (5) effects of multiple plan enrollment on quality assurance and reimbursement. Medical directors were also asked to supply information on enrollment in Medicaid managed care from institutional databases.
ANALYSIS
Responses to the questionnaire were summed, and point estimates were calculated. Chi-square tests with a Mantel-Haenszel correction and Fisher exact tests were used to test differences in proportions.
RESULTS

KNOWLEDGE OF PRIORITY AREAS FOR PEDIATRIC CARE
Medical directors and quality assurance directors of the eight largest Medicaid managed care plans in New York City were asked to name quality-of-care priorities for enrolled children. Their main priority areas were the preventive care measures that they must report to the state as part of QARR, plus asthma.
All (100%) named improving immunization coverage and improving asthma management as priorities. While fewer were able to name other QARR-reportable outcomes specifically, a full 75% said generally that QARR-reportable outcomes were priorities. Thus, although MCOs have the latitude to set performance goals beyond those required by QARR, they in fact were not doing this. MCOs further reported that they held providers responsible for the QARR-reportable preventive outcomes, while the MCOs took a more active role and responsibility in asthma management. Thus, this report focuses exclusively on QARR variables and not asthma. MCOs further reported that they communicate their priorities to the leadership in institutions, usually to the medical director, and expect the leadership to communicate with relevant staff.
Respondents at institutions were asked in general if they believed they knew the pediatric quality-of-care priorities of the MCOs, without being asked to name specific items. Not surprisingly, belief that they knew plan priority areas decreased in descending order of the institutional hierarchy (Table, first Most of the medical directors (80%) and heads of ambulatory pediatrics (77%), but fewer than half of the pediatricians (48%) in hospital clinics and neighborhood health centers, believed that they knew the plan priority areas, with differences between medical directors and pediatricians reaching statistical significance (P < .05). However, despite not knowing plan priority areas, almost all of the pediatricians in institutions (96%) stated that they had a sense of their own institution's priority areas. Since MCOs generally were communicating with the leadership of an institution and relying on leadership to communicate with physicians on staff, individual pediatricians may have been aware of, and responding to, plan priority areas without knowing this as such. In contrast, most of the private office-based physicians (75%) believed they knew the managed care plan priority areas.
Because institutions or private physicians were affiliated with at least four MCOs (and many were affiliated with more), we asked if they were able to discern differences among priority areas for different MCOs. Almost all respondents in each of the levels reported seeing no difference (from 85% to 100%) in priority areas. Many respondents added that MCOs all had essentially the same priority areas, a belief consistent with the MCO medical directors' report.
ABILITY TO NAME PRIORITY AREAS FOR LARGEST MANAGED CARE ORGANIZATION
Medical directors, heads of ambulatory pediatrics, and institutional and private pediatricians then were asked to name the specific pediatric quality-of-care priorities of the largest MCOs in their institution or practice. The Table shows the percentage of respondents who could name specific priorities identified to us by the largest MCO in each institution (immunization, lead and anemia screening).
Medical directors and private office-based providers were most able to name all three of the priority areas, with heads of ambulatory pediatrics and institutional pediatricians far less able to do so. Differences between medical directors and the institutional pediatricians were significant (P < .05) for all three priority areas, while differences between medical directors and heads of ambulatory pediatrics were significant (P < .05) for one area (lead screening) and showed a trend toward significance (P < .1) for the other two (immunization and anemia screening).
Knowledge of patient care priority areas of the institution's largest MCO decreased from medical director to head of ambulatory pediatrics to institutional physician, consistent with position in the institution and chain of communication from MCO to institution. The Table also shows that all respondent groups were best able to name immunization and, to a lesser extent, to name lead and anemia priorities of the dominant MCO. All respondents were best able to give the priority areas of the MCO with the largest enrollment and were less able to do so for the MCOs with smaller enrollments.
KNOWLEDGE OF PERFORMANCE MONITORING ACTIVITIES FOR LARGEST MANAGED CARE ORGANIZATION
To take the discussion beyond the simple knowledge of MCO-level patient care priority areas, questions were asked about actions taken by MCOs to monitor performance and to communicate results of the monitoring. Specifically, medical directors at the MCOs were asked how plans monitored performance and encouraged improvement. Follow-up questions were asked to determine whether respondents at various levels were familiar with the activities and how effective they were perceived to be.
Medical directors of the eight largest plans stated that they monitored performance for immunization coverage, lead screening, and the other QARR preventive measures through their administrative databases, supplemented with chart reviews. Administrative databases were thought to be incomplete; thus, information on performance was derived to a large extent from chart reviews. Medical directors reported that the MCOs encouraged improvement by feeding the results back to the sites.
Levels of familiarity with the monitoring activities of the largest MCO in each institution with regard to preventive screening measures followed previous trends (Table) . In institutions, medical directors claimed the greatest knowledge of activities of the largest MCO, followed by heads of ambulatory pediatrics and institutional pediatricians. Private physicians were markedly more able to name quality-monitoring activities than institutional physicians (P < .05). Thus, for immunization, 80% of medical directors were familiar with the quality-monitoring activities, while only 46% of heads of ambulatory pediatrics and 44% of institutional pediatricians could name them. This is in contrast with private physicians, of whom 80% were able to name the monitoring activities for immunization.
Levels of knowledge of monitoring were lower for the other QARR measures as a group than for immunization, but the trend of declining familiarity from medical director to institutional pediatrician persisted.
KNOWLEDGE OF MONITORING ACTIVITIES FOR FOUR LARGEST MANAGED CARE ORGANIZATIONS
In keeping with their ability to identify priorities among MCOs, each group was most familiar with the activities of the largest plan with which they deal and was less familiar with each of the smaller plans. As shown in the Table, between the first and second largest plans, knowledge of quality-monitoring activities in institutions decreased by at least 20% in three of the groups, and the decrease continued for the third and fourth largest MCOs. For the largest plan, 87% of medical directors and 69% of heads of ambulatory pediatrics were familiar with the quality-monitoring activities. Yet, only 60% of medical directors and 38% of heads of ambulatory pediatrics were familiar with the monitoring activities of the second largest plan, a significant decrease (P < .05).
Within each plan, the pattern for naming priority areas was the same, with knowledge decreasing from medical directors to heads of ambulatory pediatrics to institutional physicians and with private physicians more aware than institutional physicians, significantly so for the first and second largest plans (P < .05).
Heads of ambulatory pediatrics and institutional pediatricians were both far more familiar with the quality-monitoring activities of their own institution than they were with the quality monitoring of the largest plan (for heads of ambulatory pediatrics, 100% vs. 69%, P < .05; for institutional pediatricians, 96% vs. 48%, P < .05).
FEEDING BACK RESULTS OF" PERFORMANCE MONITORING TO PROVIDERS
Because respondents at the plan level stated that they encouraged improvement in the priority areas by feeding the results back to institutions, we asked respondents at the sites whether they received the results of the performance monitoring, limited to distribution at meetings or to physicians through the mail. Medical directors at institutions said anecdotally that the samples were so small that the results were not meaningful, and they did not stress the results internally.
EFFECTIVENESS OF QUALITY ASSURANCE ACTIVITIES OF THE PLANS
None of the respondent groups believed that the quality assurance activities of the plans were having an impact: Less than one-third of any group reported activities as "very effective" for any of the QARR outcome variables. Furthermore, respondents at all levels reported that they felt few or no incentives or disincentives from managed care plans to improve performance. For the best known priority (immunization), only 33% of the medical directors, 8% of the heads of ambulatory pediatrics, 8% of the institutional pediatricians, and 10% of the private physicians felt an incentive from managed care plans to improve performance.
However, for those that named one, the incentive named was always vague, such as a desire to practice good medicine. The largest proportion in all groups in institutions said they did not know whether or not incentives or disincentives were in place (medical directors 40%, heads of ambulatory pediatrics 46%, institutional pediatricians 52%), while the largest group of private office-based pediatricians were sure there were none (50%). No one reported feeling financial incentives for performance from MCOs.
As a final assessment of the effect of the quality assurance activities of MCOs on quality of care in institutions, heads of ambulatory pediatrics and both institutional and private pediatricians were asked whether they believed that the quality assurance standards and practices had changed in their institution due to the presence of Medicaid managed care. Most of the respondents in all groups said there had been no changes, or they did not know if there had been changes (92%, 80%, and 75%, respectively).
IMPACT OF MEDICAID MANAGED CARE ON CLINICAL AND ADMINISTRATIVE PRACTICES
Because we were not able to identify an impact in areas that plans themselves seeing more patients to the influence of managed care, but felt it was an institutional or municipal system priority as well.
There was more consistency among the respondents in both institutions and private practices as to the impact of Medicaid managed care on administrative practices, and the effects cited were negative. The most consistently cited administrative effect was that managed care created problems with referrals of patients to specialists (cited by 60% of medical directors, 77% of heads of ambulatory pediatrics, 68% of institutional physicians, and 90% of private physicians). Many respondents went on to explain that each MCO had a different referral form and its own network of specialists available to the child. Pediatricians had to know the child's MCO (something they are not accustomed to keeping in mind) so that they could fill out the correct form, and if the referral was to a named specialist, the referring pediatrician needed to verify that the specialist was in the MCO's network. Respondents most often cited this problem as an administrative issue because of the need to fill out forms properly. However, many went on to say that it is a clinical problem as well because the referral process was not functioning smoothly. Increased paperwork and administrative tasks was another impact of managed care cited by a little over half of the respondents in all groups (ranging from 52% to 65%).
PLAN DOMINANCE WITHIN INSTITUTIONS AND DISPERSION ACROSS SITES
The percentage of children on Medicaid enrolled in managed care averaged 26% among the institutions and private practices participating in the study, ranging from 6% to 48% for institutions and 2% to 90% for private practices. Each institution and private practice in the sample contracted with a minimum of four MCOs and some with many more. A number of respondents from the institutions indicated that they were contracting with as many plans as possible to maintain their pediatric patient base in the transition to managed care. one-quarter of the typical provider's Medicaid caseload was enrolled in managed care). As shown in this figure, about a quarter of the institutions and private practices (29% and 25%, respectively) had almost all (>90%) of their children in
Medicaid managed care in one plan. Further, 65% of the institutions and 55% of the private practices had 70% or more of their children in Medicaid managed care in one plan. While these institutions and practices were dominated by one plan, the situation was more mixed for the remaining providers. In fact, 14% of the institutions and 15% of the private practices had fewer than half of their children in Medicaid managed care in the largest plan for that provider.
To affect quality of care for enrolled children, plans must influence the behavior of the providers seeing those children. This task is easier for a plan if enrolled children are concentrated in a few provider sites, and that plan is clearly dominant in the sites. It is more difficult if children are dispersed across many sites, and the concentration is low in the sites. Figure 2 shows the dispersion of children enrolled in the plans in our sample across institution and private practitioner sites. As shown in this figure, most plans had a few sites with a high proportion of children and many sites with few children. Taken together, the plans represented in the provider sites in our sample had 10 institutions and 11 private provider sites in which they were dominant (more than 70% of the children).
However, the plans in our sample, taken together, had 28 institutions and 34 private provider sites with small proportions of children (fewer than 30%). This distribution of children over many sites has implications for logistics of monitoring, cost of monitoring, and level of influence a given plan can exert. 
INSTITUTIONS AS INTERMEDIARIES BETWEEN PLANS AND PROVIDERS
The approach of states in the regulation of MCOs and MCOs in the regulation of providers is based on a belief that MCOs exert a level of control over physicians that will allow them to accomplish quality goals. However, MCOs in New York and elsewhere do not contract directly with many of their network physicians.
Rather, they often contract with community health centers, hospitals, and other institutions, which then oversee the performance of physicians. While the clinic leadership was aware of MCO priorities and quality monitoring, the pediatricians actually delivering care were not, and they did not feel incentives--financial or otherwise--from MCOs for performance, although they were aware acutely of institutional priorities, quality monitoring, and incentives. Even if institutional 
PROBLEMS WITH MONITORING AND JNFLUENCING PERFORMANCE
The findings of this study also raise questions about the strategy of the MCOs for monitoring and influencing performance at the provider level. The MCOs studied here monitored provider performance by feeding back the results to providers from the same sample of children on which the QARR results were based. For most measures, these were based on a sample of 411 children (enrolled continuously for 12 months) planwide. While requirements permit MCOs to report performance of all members who meet the age and enrollment requirements using data in their own administrative databases, for the most part, MCOs did not do this. Instead, they reported performance on a systematic sample of children (usually 411) and relied heavily on chart reviews to augment the oftenincomplete information in administrative databases, s Feedback to providers consisted of notifying them of the performance of their children who happened to be drawn in the MCO-wide systematic sample of 411. However, because the 411 children were spread across numerous providers, the sample size drawn from any one site was too small for effective monitoring. Indeed, we found that most providers were not using the feedback reports that MCOs mentioned as the linchpin to their quality improvement efforts. Some providers specifically mentioned that the reports were not valid due to the small sample size. Given that states report increased reliance on provider feedback reports to ensure and improve quality, 6 these limitations represent serious problems. each month, making it difficult to generate a large sample of continuously enrolled children, z5 Ironically, the children excluded from quality assurance sampling--those experiencing gaps in coverage--are probably at greatest risk for inappropriate or otherwise low-quality care.
NEED FOR NEW MODELS OF PERFORMANCE OVERSIGHT
In keeping with our observations, some authors are calling for the delegation of quality improvement activities to constituent provider groups and the exploration of collaborative approaches to quality improvement. 26r The individual provider, not the MCO, provides the care. It is not realistic to expect each MCO to monitor performance of all providers who see MCO enrollees, especially with the large dispersion of enrollees across sites. Further, not only would this represent a burden to MCOs, but the provider is less likely to respond to an MCO that has a small proportion of the patients of the site. A provider-focused, rather than an MCO-focused, approach to quality may offer a more suitable framework for coordinating and reinforcing multiple activities (including those required of MCOs) aimed at improving care for a stable population of low-income children.
Provider-oriented approaches can foster population-based medicine better and may yield more direct benefits to children remaining in the fee-for-service Medicaid, those served by other insurance programs (such as the State Child Health Insurance Program), and potentially those who remain uninsured. Collaborative activity among providers, MCOs, and states could also reduce the inefficiencies and intrusion caused by having many health plans ask for the same information.
LIMITATIONS
Limitations of this study include the fact that it relied on report and perceptions of respondents. Perceptions are useful, but not always accurate. Specifically, in this study, institutional pediatricians may not have been able to report the impact of managed care correctly because they perceived the impact as coming from the institution. Related to this, because the study did not examine the feedback from the MCOs, it was not possible to determine whether the problem was with feedback or perception and memory. A second limitation is that it was conducted during the voluntary phase of managed care and only 3 to 4 years after MCOs began reporting to the state; Results may be different after more time. Finally, it is a study of MCO impact in one environment: New York City. However,
given that the features we describe in New York City exist elsewhere, we believe that the results have broad application.
